These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31943281)

  • 21. Tamoxifen-independent recombination in the RIP-CreER mouse.
    Liu Y; Suckale J; Masjkur J; Magro MG; Steffen A; Anastassiadis K; Solimena M
    PLoS One; 2010 Oct; 5(10):e13533. PubMed ID: 21063464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When Cre-mediated recombination in mice does not result in protein loss.
    Turlo KA; Gallaher SD; Vora R; Laski FA; Iruela-Arispe ML
    Genetics; 2010 Nov; 186(3):959-67. PubMed ID: 20813881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promiscuous recombination of LoxP alleles during gametogenesis in cornea Cre driver mice.
    Weng DY; Zhang Y; Hayashi Y; Kuan CY; Liu CY; Babcock G; Weng WL; Schwemberger S; Kao WW
    Mol Vis; 2008 Mar; 14():562-71. PubMed ID: 18385792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand-Controlled Site-Specific Recombination in Zebrafish.
    Chekuru A; Kuscha V; Hans S; Brand M
    Methods Mol Biol; 2017; 1642():87-97. PubMed ID: 28815495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gcg
    Shiota C; Prasadan K; Guo P; Fusco J; Xiao X; Gittes GK
    Diabetologia; 2017 Dec; 60(12):2399-2408. PubMed ID: 28884202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel reporter and deleter mouse strains generated using VCre/VloxP and SCre/SloxP systems, and their system specificity in mice.
    Yoshimura Y; Ida-Tanaka M; Hiramaki T; Goto M; Kamisako T; Eto T; Yagoto M; Kawai K; Takahashi T; Nakayama M; Ito M
    Transgenic Res; 2018 Apr; 27(2):193-201. PubMed ID: 29546522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporally controlled somatic mutagenesis in smooth muscle.
    Kühbandner S; Brummer S; Metzger D; Chambon P; Hofmann F; Feil R
    Genesis; 2000 Sep; 28(1):15-22. PubMed ID: 11020712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of a Mouse Model with Smooth Muscle Cell Specific Loss of the Expression of PPARγ.
    Rautureau Y; Paradis P; Schiffrin EL
    Methods Mol Biol; 2017; 1527():381-407. PubMed ID: 28116732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
    Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional gene expression in the mouse inner ear using Cre-loxP.
    Cox BC; Liu Z; Lagarde MM; Zuo J
    J Assoc Res Otolaryngol; 2012 Jun; 13(3):295-322. PubMed ID: 22526732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of whole-body gene deletion
    Kumar R; Mao Y; Patial S; Saini Y
    Front Pharmacol; 2022; 13():1018798. PubMed ID: 36569322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
    Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen-Induced Cre-loxP Recombination Is Prolonged in Pancreatic Islets of Adult Mice.
    Reinert RB; Kantz J; Misfeldt AA; Poffenberger G; Gannon M; Brissova M; Powers AC
    PLoS One; 2012; 7(3):e33529. PubMed ID: 22470452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted knock-in of CreER
    Kesavan G; Hammer J; Hans S; Brand M
    Cell Tissue Res; 2018 Apr; 372(1):41-50. PubMed ID: 29435650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A shortened tamoxifen induction scheme to induce CreER recombinase without side effects on the male mouse skeleton.
    Jardí F; Laurent MR; Dubois V; Khalil R; Deboel L; Schollaert D; Van Den Bosch L; Decallonne B; Carmeliet G; Claessens F; Vanderschueren D
    Mol Cell Endocrinol; 2017 Sep; 452():57-63. PubMed ID: 28504114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced DNA recombination by Cre recombinase protein transduction.
    Joshi SK; Hashimoto K; Koni PA
    Genesis; 2002 May; 33(1):48-54. PubMed ID: 12001069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent.
    Vooijs M; Jonkers J; Berns A
    EMBO Rep; 2001 Apr; 2(4):292-7. PubMed ID: 11306549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.